#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Sleep apnea and cardiovascular disease


Authors: Ondřej Ludka
Authors‘ workplace: Mezinárodní centrum klinického výzkumu, FNUSA, Brno ;  I. interní kardioangiologická klinika LF MU a FN u sv. Anny, Brno
Published in: Čas. Lék. čes. 2019; 158: 178-184
Category: Review Article

Overview

Sleep is a condition of physiological relaxation for the cardiovascular system, and sleep-disordered breathing disturbs it. Recurrent episodes of sleep apnea disrupt the physiological interactions between sleep and the cardiovascular system. Sleep apnea can affect not only patients’ quality of life with cardiovascular diseases, but also their morbidity and mortality. Thus sleep apnea becomes a significant, influential risk factor in cardiology.

Keywords:

sleep apnoea – sleep-disordered breathing


Sources
  1. Tkáčová R, Hall MJ, Liu PP et al. Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 1997; 156: 1549–1555.

  2. Marin JM, Carrizo SJ, Vicente E et al. Long-term cardiovascular outcomes in men with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.

  3. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 2015; 7(8): 1311–1322.

  4. Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008; 52: 686–717.

  5. Hermida RC, Zamarron C, Ayala DE et al. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit 2004; 9: 193–202.

  6. Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001; 19: 2271–2277.

  7. Suzuki M, Guilleminault C, Otsuka K et al. Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients. Sleep 1996; 19: 382–387.

  8. Malik J, Drake CL, Hudgel DW. Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients. Sleep Breath 2008; 12: 47–52.

  9. Ludka O, Štěpánová R, Vyskočilová M et al. Sleep apnea prevalence in acute myocardial infarction – the Sleep Apnea in Post-acute Myocardial Infarction Patients (SAPAMI) Study. Int J Cardiol 2014; 176(1): 13–9.

  10. Huang Z, Zheng Z, Luo Y et al. Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis. Sleep Breath 2017; 21(1): 217–226.

  11. Quyyumi AA, Efthimiou J, Quyyumi A et al. Nocturnal angina: precipitating facators in patients with coronary artery disease and those with variant angina. Br Heart J 1986; 56: 346–352.

  12. Yumino D, Tsurumi Y, Takagi A et al. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007; 99: 26–30.

  13. Ludka O, Štěpánová R, Sert-Kuniyoshi F et al. Differential likelihood of NSTEMI vs STEMI in patients with sleep apnea. Int J Cardiol 2017; 248: 64–68.

  14. Philip P, Guilleminault C. ST segment abnormality, angina during sleep and obstructive sleep apnea. Sleep 1993;16: 558–559.

  15. Milleron O, Pillière R, Foucher A et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. EurHeart J 2004; 25: 728–734.

  16. McEvoy RD, Antic NA, Heeley E et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016; 375(10): 919–931.

  17. Wang X, Zhang Y, Dong ZM et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis. Respir Res 2018; 19: 61.

  18. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490–494.

  19. Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173: 910–916.

  20. Garrigue S, Pepin JL, Defaye P et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115: 1703–1709.

  21. Koehler U, Fus E, Grimm W et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998; 11: 434–439.

  22. Craig S, Pepperell JC, Koulet M et al. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhytmias: a randomised controlled trial. J Sleep Res 2009; 18: 329–336.

  23. Gami AS, Pressman G, Caples SM et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364–367.

  24. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006; 106: 21–28.

  25. Matiello M, Nadal M, Tamborero D et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 2010; 12(8): 1084–1089.

  26. Kanagala R, Murali NS, Friedman PA et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589–2594.

  27. Koshino Y, Satoh M, Katayose Y et al. Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure. Am J Cardiol 2008; 101: 882–886.

  28. Shepard JW jr., Garrison MW, Grither DA et al. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985; 88: 335–340.

  29. Monahan K, Storfer-Isser A, Mehra R et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 2009; 54: 1797–1804.

  30. Ryan CM, Juvet S, Leung R et al. Timing of nocturnal ventricular ectopy in heart failure patients with sleep apnea. Chest 2008; 133: 934–940.

  31. Bitter T, Westerheide N, Prinz Ch et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011; 32: 61–74.

  32. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352(12): 1206–1214.

  33. Ahn SH, Kim JH, Kim DU et al. Interaction between sleep-disordered breathing and acute ischemic stroke. J Clin Neurol 2013; 9: 9–13.

  34. Levy LM, Pepin J-L, Tamisier R et al. Prevalence and impact of central sleep apnea in heart failure. Sleep Med Clin 2007; 2: 615–621.

  35. Bitter T, Faber L, Hering D et al. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 2009; 11: 602–608.

  36. Yumino D, Wang H, Floras JS et al. Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 2009; 95(10): 819–24.

  37. Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233–1241.

  38. Arzt M, Floras JS, Logan AG et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial. Circulation 2007; 115: 3173–3180.

  39. Kasai T, Usui Y, Yoshioka T et al. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 2010; 3: 140–148.

  40. Nakamura S, Asai K, Kubota Y et al. Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis. Clin Res Cardiol 2015; 104(3): 208–16.

  41. Cowie MR, Woehrle H, Wegscheider K et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 2015; 373: 1095–105.

  42. Galie N, Humbert M, Vachieryc JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37: 67–119.

  43. Konečný T, Geske J, Ludka O et al. Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy. Chest 2015; 147(6): 1574–1581.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#